Loading clinical trials...
Loading clinical trials...
An Open-label, Non-randomized, Phase I/II Study of Autologous Bone Marrow-Derived Mononuclear Stem Cells (BM-MNC) and Liberation Therapy (When Associated With CCSVI) in Patients With RRMS
Conditions
Interventions
Autologous Bone Marrow-Derived Mononuclear Stem Cells
Liberation therapy
Locations
2
India
Inamdar Multispecialty Hospital
Pune, Maharashtra, India
Novo Cellular Medicine Institute
San Fernando, Trinidad, Trinidad and Tobago
Start Date
February 1, 2015
Primary Completion Date
February 1, 2017
Completion Date
February 1, 2017
Last Updated
October 28, 2015
NCT05359653
NCT06390930
NCT03401879
NCT06389968
NCT05834855
NCT06413602
Lead Sponsor
Novo Cellular Medicine Institute LLP
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions